Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

980 trials

NCT06736574
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Phase 3 · Canada, China, Germany, Spain, France, United Kingdom, Greece, Italy, Poland, United States · 214 sites
Registry update: 4 Nov 2026
NCT05672836
Recruiting
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Phase 4 · South Korea · 31 sites
Registry update: 29 Jun 2026
NCT06241430
Recruiting
The CardioClip Study
Not applicable · United States · 1 site
Registry update: 29 Jun 2026
NCT05879276
Recruiting
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Phase 3 · France · 8 sites
Registry update: 27 Jun 2025
NCT06526195
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Not applicable · Austria, Czechia, Germany, Denmark, Italy, Netherlands, Saudi Arabia, United States · 70 sites
Registry update: 5 Nov 2026
NCT07443670
Recruiting
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
Not applicable · Germany, United States · 3 sites
Registry update: 2 Mar 2026
NCT06507657
Recruiting
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
Early phase 1 · United States · 1 site
Registry update: 20 Oct 2026
NCT06978998
Recruiting
Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF
Not applicable · South Korea · 1 site
Registry update: 18 May 2025
NCT06299436
Recruiting
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
Not applicable · United States · 1 site
Registry update: 12 Jan 2026
NCT06597019
Recruiting
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · Argentina, Austria, Belgium, Brazil, China, Czechia, Germany, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Israel, Italy, Malaysia, Netherlands, Poland, Portugal, Taiwan, United States, South Africa · 60 sites
Registry update: 15 May 2026
NCT06688396
Recruiting
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Not applicable · United States · 1 site
Registry update: 30 Jan 2025
NCT06800716
Recruiting
Impella Reverse Remodeling in End-Stage Heart Failure
Not applicable · United States · 1 site
Registry update: 19 Aug 2026
NCT06714344
Recruiting
Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
Not applicable · Austria · 2 sites
Registry update: 19 Feb 2025
NCT06896266
Recruiting
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
Not applicable · Spain · 4 sites
Registry update: 15 Sept 2026
NCT06915584
Recruiting
Drug Management in Heart Failure
Not applicable · Italy · 1 site
Registry update: 20 Oct 2026
NCT06656832
Recruiting
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Not applicable · Germany · 1 site
Registry update: 6 May 2026
NCT07820410
Recruiting
Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction
Phase 2/3 · China · 1 site
Registry update: 15 Sept 2026
NCT06336746
Recruiting
Cardiac Performance During Steep Trendelenburg Position in Patients Undergoing Robotic Surgery Surgery.
Not applicable · Sweden · 1 site
Registry update: 12 Feb 2026
NCT06699056
Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Not applicable · United States · 8 sites
Registry update: 1 Jun 2026
NCT06705023
Recruiting
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Phase 2 · Kazakhstan · 1 site
Registry update: 3 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.